A Banner Witcoff team successfully represented Clear-Vu Lighting as petitioner in an inter partes review (IPR) of a patent directed to using blue light to inactivate certain types of bacteria.
Clear-Vu initiated the IPR proceeding against the patent owner, University of Stratchclyde, after its exclusive licensee, Kenall Manufacturing, alleged the patent was infringed. The U.S. Patent Trial and Appeal Board (PTAB) sided with Clear-Vu in a decision issued on July 9, finding that the patent’s claims directed to using blue light to inactivate certain types of bacteria such as MRSA were invalid.
The Banner Witcoff team was led by Brian Emfinger and Binal Patel, and included Matt Becker, Chris Galfano and Blair Silver. Paralegals Carlos Goldie, Yolanda Cameron and Valerie Koleno provided support.
Banner Witcoff is recognized as one of the best performing and most active law firms representing clients in IPR proceedings. To learn more about our team of seasoned attorneys and their capabilities and experience at the PTAB, click here.
Posted: July 13, 2020
